Stryker has "always" had a strong financial position with lots of cash and great management. In trying markets investors are seeking rock-solid companies that can weather the rough seas that we are experiencing. As the Baby-Boomers age (along with their hips, knees, etc.) the demand for orthopaedic products has to keep pace. If you look at a chart of Stryker's performance over the past twenty-so years you see steady growth and, with four splits thrown in, an overall PPS increase of over 8,000%! Steady dividends- steady double digit growth! Innovative, flexible and worthy of a strong buy! (Conference call coming up very soon!)
$62.64 (07/06/08)
